Loading...

Insulet Corporation

PODDNASDAQ
HealthcareMedical - Devices
$311.77
$-5.39(-1.70%)

Insulet Corporation (PODD) Company Profile & Overview

Explore Insulet Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Insulet Corporation (PODD) Company Profile & Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

SectorHealthcare
IndustryMedical - Devices
CEOMs. Ashley A. McEvoy

Contact Information

978 600 7000
100 Nagog Park, Acton, MA, 01720

Company Facts

3,900 Employees
IPO DateMay 15, 2007
CountryUS
Actively Trading

Frequently Asked Questions